Ionis to Hold Second Quarter 2024 Financial Results Webcast
Ionis to Hold Second Quarter 2024 Financial Results Webcast
Webcast scheduled for Thursday, August 1 at 11:30 a.m. Eastern Time
网络直播预定于美国东部时间8月1日上午11:30进行
CARLSBAD, Calif., July 19, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Thursday, August 1st at 11:30 a.m. Eastern Time to discuss its second quarter 2024 financial results.
加州卡尔斯巴德，2024年7月19日 /美通社/ -- Ionis制药公司（纳斯达克：IONS）今天宣布，将于美国东部时间8月1日上午11:30举行现场网络直播，讨论其2024年第二季度财务业绩。
The webcast may be accessed at . A replay will be available for a limited time at the same address.
可通过下面链接访问网络直播。重播地址同样有效，但时间有限。
About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.
关于Ionis Pharmaceuticals，Inc.
三十年来，Ionis一直致力于发明能为重症患者带来更美好未来的药物。Ionis目前拥有五种上市药品，以及神经病学、心脏病学和其他高患者需求领域的领先管线。作为RNA靶向药物的先驱，Ionis在RNA疗法方面持续推动创新并推进基因编辑的新方法。对疾病生物学的深入理解和行业领先的技术推动我们的工作，加上为患者提供改变生命的进展的热情和紧迫感。欲了解更多关于Ionis的信息，请访问Ionis.com并关注我们的推特和领英。
Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – [email protected] – 760-603-2331
Ionis制药投资者联系方式：
D. Wade Walke, Ph.D. – [email protected] – 760-603-2331
Ionis Pharmaceuticals Media Contact:
Hayley Soffer – [email protected] – 760-603-4679
Ionis制药媒体联系人：
Hayley Soffer – [email protected] – 760-603-4679
SOURCE Ionis Pharmaceuticals, Inc.
资料来源：Ionis Pharmaceuticals, Inc.